BCI

Allianz Trade & Inclusive Brains join forces to foster the inclusion of people with disabilities thanks to AI and neurotechnologies

Retrieved on: 
星期二, 五月 7, 2024
Health Technology, Security, Insurance, Technology, Finance, Fintech, Banking, Professional Services, Neurology, Artificial Intelligence, People with Disabilities, Biotechnology, Payments, Consumer, Health, Education, Brain, Language, System, Disability studies, Safety, Disability, AI, Heart, LLM, BCI, Partnership, Workplace, Artificial intelligence, Blinking, Intelligence, Science, International Paralympic Committee, Facial muscles, Intellectual disability, Acquisition, Interface (computing), Face, Workforce, Paralysis, Organization, Medical device

Eventually, the Allianz Trade and Inclusive Brains partnership will accelerate the development of AI-powered assistive solutions that give people with disabilities more autonomy and facilitate their access to education and to the workforce.

Key Points: 
  • Eventually, the Allianz Trade and Inclusive Brains partnership will accelerate the development of AI-powered assistive solutions that give people with disabilities more autonomy and facilitate their access to education and to the workforce.
  • “Inclusive Brains’ generative AI models and multimodal neural interfaces will benefit everybody, regardless of their physicality, abilities, and needs, however special they might be.
  • This is where Allianz Trade comes in: by partnering with Inclusive Brains, Allianz Trade will bring some important resources to the project on financial, strategic and visibility matters.
  • We are therefore delighted to be partnering with Allianz Trade, since our goals are aligned: to leverage technology and AI for the better good,” adds Paul Barbaste, Co-founder and CTO of Inclusive Brains.

Neurable Inc. Raises $13M Paving the Way for Brain-Computer Interface Technology in Everyday Products

Retrieved on: 
星期二, 五月 7, 2024
Wearables, Mobile Technology, Hardware, Technology, Artificial Intelligence, Software, Brain, University, Master & Dynamic, Woman, Health, BCI, Partnership, TRAC, Original equipment manufacturer, Entrepreneurship, Science, University of Michigan, EEG, Electroencephalography, Algorithm

“Neurable's transformative neurotechnology is at the forefront of the BCI revolution,” said Dale Davis, Senior Principal at Ultratech Capital Partners. “BCI technology has gained significant momentum over the years, and its advancement shows no signs of slowing down. Neurable’s BCI has the potential to solve a range of vexing issues -- from healthcare to daily life. BCI integrated into our devices, and a critical part of our everyday experience was once the stuff of science fiction -- thanks to Neurable, that dream will soon be a reality.”

Key Points: 
  • This includes expanding its product portfolio, reference designs, algorithms, and enabled systems to include earbuds, helmets, and various head-worn devices that will help optimize human performance.
  • “This new round of funding underscores our commitment to making Neurable’s brain-computer interface technology accessible to everyone,” said Dr. Ramses Alcaide, CEO and Co-Founder of Neurable.
  • “Neurable's transformative neurotechnology is at the forefront of the BCI revolution,” said Dale Davis, Senior Principal at Ultratech Capital Partners.
  • “BCI technology has gained significant momentum over the years, and its advancement shows no signs of slowing down.

Tropicana Brands Group Appoints Olu Beck to Board of Directors

Retrieved on: 
星期一, 五月 6, 2024
PepsiCo, EVP, BCI, Partnership, Saputo Inc., PAI Partners, Development, Mars, Crown corporations of Canada, Mars, Incorporated, TBG, CPG, Management

CHICAGO, May 6, 2024 /PRNewswire/ -- Tropicana Brands Group (TBG), the leader in fresh and chilled beverages, today announced the appointment of Olu Beck to its Board of Directors effective May 6, 2024. In this role, Ms. Beck will primarily focus on guiding TBG through its next phase of innovation and sustainable growth.

Key Points: 
  • Ms. Beck joins as the ninth and final Board Member, rounding out an esteemed group of advisors charged with guiding the joint venture's trajectory
    CHICAGO, May 6, 2024 /PRNewswire/ -- Tropicana Brands Group (TBG), the leader in fresh and chilled beverages, today announced the appointment of Olu Beck to its Board of Directors effective May 6, 2024.
  • In this role, Ms. Beck will primarily focus on guiding TBG through its next phase of innovation and sustainable growth.
  • "Olu's extraordinary vision and dedication to the Consumer-Packaged Goods industry align seamlessly with Tropicana Brands Group's mission to nourish and delight one sip at a time and drive transformational growth," says Glen Walter, CEO of Tropicana Brands Group.
  • "Tropicana Brands Group has an exciting story and opportunity that is unique to the CPG and beverage industry," says Olu Beck.

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date

Retrieved on: 
星期四, 四月 25, 2024
FDA, De novo, Partnership, EUR, TAP, Spinal cord, Lead, BDD, Defense, American Academy, Class, MJFF, Equity, Safety, ARC, BCI, Euronext, Research, University, Hemiunu, Global marketing, Government, SCI, Nature Medicine, Paralysis, Movement, SDVOSB, Pharmaceutical industry

The Company is developing a portfolio of ARC-IM Leads, each optimized for placement on a different area of the spinal cord.

Key Points: 
  • The Company is developing a portfolio of ARC-IM Leads, each optimized for placement on a different area of the spinal cord.
  • Also in November, ONWARD Medical research partner .NeuroRestore was awarded a $1 million grant from The Michael J.
  • In Q2, Bryan, Garnier & Co reinitiated research coverage of ONWARD Medical following the appointment of a new equity research analyst.
  • For 2023, the Company reported an operating loss of EUR 35.5M compared to EUR 32.0M in 2022.

ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast

Retrieved on: 
星期四, 四月 11, 2024
SCI, ARC, BCI, Euronext, Webcast, Movement, Interim, Broadcasting

EINDHOVEN, the Netherlands, April 11, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will publish Full Year 2023 Financial Results and host a webcast to discuss business highlights.

Key Points: 
  • EINDHOVEN, the Netherlands, April 11, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will publish Full Year 2023 Financial Results and host a webcast to discuss business highlights.
  • The webcast will be held on April 25, 2024, at 2:00PM CET / 08:00AM ET.
  • It will be hosted by CEO Dave Marver and Interim CFO Khaled Bahi, who will discuss highlights from 2023 and provide a business update.
  • Participants may also join by phone:
    A recording of the webcast will be available on the Company’s website following the live event.

Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology

Retrieved on: 
星期四, 四月 25, 2024
Research, Medical Devices, Genetics, Clinical Trials, Health Technology, Biotechnology, Health, Optical, Science, Diamond, Blog, Stanford University, AMD, IP, Cell, Corporation, RP, Retinitis pigmentosa, BCI, Paratriathlon, Trigeminal ganglion, Retina, PRIMA, Patient, Acquisition, Optic nerve, Clinical trial, Medical imaging

Science Corporation (“Science”), a leader in brain-computer interface (“BCI”) technology and the developer of the Science Eye , has acquired the IP and related assets for the PRIMA retinal implant , developed by Pixium Vision SA (“Pixium”) of France, a bioelectronics BCI technology company.

Key Points: 
  • Science Corporation (“Science”), a leader in brain-computer interface (“BCI”) technology and the developer of the Science Eye , has acquired the IP and related assets for the PRIMA retinal implant , developed by Pixium Vision SA (“Pixium”) of France, a bioelectronics BCI technology company.
  • Together with the work being done at Science on the Science Eye, we now have two great opportunities to develop BCI technology for the potential restoration of vision in certain patients with severe vision loss.
  • Pixium’s PRIMA system features a miniaturized, wireless, subretinal implant (originally developed at Stanford University) paired with a pocket computer, and glasses.
  • Science CEO Hodak continued: “Science is now developing advanced innovative products using two very different modalities.

CleanTech Strategies Selected by U.S. Department of Energy to Advance Innovations in Flow Batteries, with Close Industry Collaboration

Retrieved on: 
星期二, 四月 23, 2024
Public sector, DOE, EEI, Storage, PNNL, BCI, Pacific Northwest National Laboratory, R&D, Partnership, Office of Electricity, Research, Battery Council International, Inflation, EPRI, Edison Electric Institute, Private sector, CTS, OE, Electric Power Research Institute, Clean technology, Knowledge, Renewable energy

SEATTLE, April 23, 2024 /PRNewswire/ -- Clean technology expert firm CleanTech Strategies (CTS) has been selected by the U.S. Department of Energy (DOE)'s Office of Electricity (OE) as one of three selectees to receive a $5 million award each to advance energy storage innovations to help deliver clean, affordable electricity to Americans. The DOE OE awards are through the Storage Innovations 2030: Technology Liftoff funding opportunity announcement.

Key Points: 
  • SEATTLE, April 23, 2024 /PRNewswire/ -- Clean technology expert firm CleanTech Strategies (CTS) has been selected by the U.S. Department of Energy (DOE)'s Office of Electricity (OE) as one of three selectees to receive a $5 million award each to advance energy storage innovations to help deliver clean, affordable electricity to Americans.
  • CTS appreciates DOE OE's further support of flow battery innovations, building on its sustained efforts for two decades.
  • CTS very much appreciates DOE OE's further support of flow battery innovations under the Storage Innovations 2030 program, which builds on its sustained efforts for two decades."
  • FBIG was established in 2023 as part of BCI in collaboration with CTS, and has grown into an industry-leading platform for industry collaboration and advancement.

Trojan Battery Company Receives Top 2024 BCI Amplify Award

Retrieved on: 
星期二, 四月 23, 2024
Safety, BCI, AES, Communication, Trojan, Battery Council International, Gold, Silver, AGM, Arms industry

FORT LAUDERDALE, Fla., April 23, 2024 /PRNewswire/ -- Trojan Battery Company has been awarded the top 2024 BCI Amplify Award for its innovative and effective "Say Yes to Trojan AES!" campaign to generate awareness for the new Trojan advanced energy storage (AES) AGM battery.

Key Points: 
  • FORT LAUDERDALE, Fla., April 23, 2024 /PRNewswire/ -- Trojan Battery Company has been awarded the top 2024 BCI Amplify Award for its innovative and effective "Say Yes to Trojan AES!"
  • "Trojan Battery Company strategically highlighted and effectively communicated these attributes with its Trojan AES battery campaign, and Battery Council International is pleased to recognize the company's work."
  • "We are honored to receive the 2024 BCI Amplify Award for our highly successful Trojan AES marketing campaign.
  • It helped us successfully launch the product while simultaneously positioning Trojan as a market innovator," said Jane Ito, Vice President of Marketing, C&D Technologies and Trojan Battery Company.

ENTEK Receives 2024 BCI Innovation Award

Retrieved on: 
星期一, 四月 22, 2024
Culture, BCI, Innovation, Battery Council International, Renewable energy

FORT LAUDERDALE, Fla., April 22, 2024 /PRNewswire/ -- ENTEK International LLC has been awarded the 2024 BCI Innovation Award for its solvent-free separator technology, providing a more environmentally friendly alternative that does not sacrifice strength or performance.

Key Points: 
  • FORT LAUDERDALE, Fla., April 22, 2024 /PRNewswire/ -- ENTEK International LLC has been awarded the 2024 BCI Innovation Award for its solvent-free separator technology, providing a more environmentally friendly alternative that does not sacrifice strength or performance.
  • "Battery Council International is proud to recognize ENTEK, and the spirit of progress that its innovative solution represents for this industry."
  • Battery Council International annually presents this award to celebrate innovation in equipment, processes, services, and products that advance the battery industry.
  • The award was established to honor industry thought leader, Sally Breidegam Miksiewicz, former CEO of East Penn Manufacturing Co.
    To watch a video of each submission to this year's BCI Innovation Award and to learn more about the annual contest, visit batterycouncil.org/about/innovation-award .

Tel Aviv Sourasky Medical Center (TASMC) partners with the AI innovator NeuroBrave to bring Generative AI into the field of BCI (Brain-Computer Interfaces)

Retrieved on: 
星期三, 四月 17, 2024
Brain, TEL, BCI, DSM-IV codes, Interface (computing), Computer, Partnership, Research, Speech, Neuralink, Patient, Spinal cord, Health, Brain–computer interface, Mobile phone

TEL AVIV, Israel, April 17, 2024 /PRNewswire/ -- The Functional Neurosurgery Unit, a part of the Department of Neurosurgery at the Tel Aviv Sourasky Medical Center (TASMC), specializes in treating brain, spinal cord, and peripheral nervous system disorders, is considered the leading in Israel, and one of the most advanced internationally, announcing today the partnership, aiming to reach new frontiers in the BCI (Brain-Computer Interface) field and accelerate the research and implementation of innovative solutions for complex neurological conditions and patient care. 

Key Points: 
  • The collaboration will yield real-time translation of thoughts and intentions, allowing completely paralyzed patients to intuitively communicate with those around them, and operate computers, mobile phones, and other devices.
  • The hospital and the company signed a research and commercial cooperation agreement.
  • "For more than a decade, our clinical research team has been at the forefront of speech decoding and brain information research and has accumulated a vast amount of know-how and data," said Dr. Ido Strauss, head of the Functional Neurosurgery Unit at the Sourasky Medical Center.
  • "The partnership with NeuroBrave opens exciting possibilities to take the next step in brain-computer interfaces, translate brain activity into speech, and help patients with various brain disorders to communicate."